This menu provides the list of EV proteins identified by high-throughput analyses.

Search:
Superdomain: All Prokaryote Eukaryote
Filter datasets:
  - "Sample type" indicates the source from which EVs originated (e.g. B cell, serum).
  - "Sample status" indicates the condition of the source from which EVs originated (e.g. Normal, miR-146a-treated, Patients of hernia).
Number of molecules in one page:

The downloaded CSV file is not exactly the same as the displayed table. Opening CSV file with Excel can impair its content.

Protein name UniProt accession Publication Orthologous group Identification count
All / Prokaryote / Eukaryote
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Exosomes with immune modulatory features are present in human breast milk.
J Immunol. 2007 Aug 1;179(3):1969-78.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Proteomic analysis of microvesicles derived from human colorectal cancer cells.
J Proteome Res. 2007 Dec;6(12):4646-55. Epub 2007 Oct 24.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Comparative proteomic analysis of PAI-1 and TNF-alpha-derived endothelial microparticles.
Proteomics. 2008 Jun;8(12):2430-46. doi: 10.1002/pmic.200701029.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Large-scale proteomics and phosphoproteomics of urinary exosomes.
J Am Soc Nephrol. 2009 Feb;20(2):363-79. doi: 10.1681/ASN.2008040406. Epub 2008 Dec 3.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Proteomic analysis of human parotid gland exosomes by multidimensional protein identification technology (MudPIT).
J Proteome Res. 2009 Mar;8(3):1304-14. doi: 10.1021/pr800658c.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Proteomic analysis of malignant B-cell derived microparticles reveals CD148 as a potentially useful antigenic biomarker for mantle cell lymphoma diagnosis.
J Proteome Res. 2009 Jul;8(7):3346-54. doi: 10.1021/pr801102c.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Differential stimulation of monocytic cells results in distinct populations of microparticles.
J Thromb Haemost. 2009 Jun;7(6):1019-28. doi: 10.1111/j.1538-7836.2009.03434.x.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Differential stimulation of monocytic cells results in distinct populations of microparticles.
J Thromb Haemost. 2009 Jun;7(6):1019-28. doi: 10.1111/j.1538-7836.2009.03434.x.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Hypoxic tumor cell modulates its microenvironment to enhance angiogenic and metastatic potential by secretion of proteins and exosomes.
Mol Cell Proteomics. 2010 Jun;9(6):1085-99. doi: 10.1074/mcp.M900381-MCP200. Epub 2010 Feb 1.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Proteomics analysis of bladder cancer exosomes.
Mol Cell Proteomics. 2010 Jun;9(6):1324-38. doi: 10.1074/mcp.M000063-MCP201. Epub 2010 Mar 11.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769The plasma microparticle proteome.
Semin Thromb Hemost. 2010 Nov;36(8):845-56. doi: 10.1055/s-0030-1267038. Epub 2010 Nov 3.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Protein profile of exosomes from trabecular meshwork cells.
J Proteomics. 2011 May 16;74(6):796-804. doi: 10.1016/j.jprot.2011.02.024. Epub 2011 Mar 8.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulinF5H6I0Proteomic analysis of microvesicles derived from human colorectal cancer ascites.
Proteomics. 2011 Jul;11(13):2745-51. doi: 10.1002/pmic.201100022. Epub 2011 Jun 1.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Proteomic analysis of microvesicles derived from human colorectal cancer ascites.
Proteomics. 2011 Jul;11(13):2745-51. doi: 10.1002/pmic.201100022. Epub 2011 Jun 1.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulinP07151Proteolipidic composition of exosomes changes during reticulocyte maturation.
J Biol Chem. 2011 Sep 30;286(39):34426-39. doi: 10.1074/jbc.M111.257444. Epub 2011 Aug 2.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulinP07151Proteolipidic composition of exosomes changes during reticulocyte maturation.
J Biol Chem. 2011 Sep 30;286(39):34426-39. doi: 10.1074/jbc.M111.257444. Epub 2011 Aug 2.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulinP07151Proteomics of microparticles after experimental pulmonary embolism.
Thromb Res. 2012 Jul;130(1):122-8. doi: 10.1016/j.thromres.2011.09.016. Epub 2011 Oct 19.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulinP07151Proteomics of microparticles after experimental pulmonary embolism.
Thromb Res. 2012 Jul;130(1):122-8. doi: 10.1016/j.thromres.2011.09.016. Epub 2011 Oct 19.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Expression of PTRF in PC-3 Cells modulates cholesterol dynamics and the actin cytoskeleton impacting secretion pathways.
Mol Cell Proteomics. 2012 Feb;11(2):M111.012245. doi: 10.1074/mcp.M111.012245. Epub 2011 Oct 26.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulinP01887Exosomes from Plasmodium yoelii-infected reticulocytes protect mice from lethal infections.
PLoS One. 2011;6(10):e26588. doi: 10.1371/journal.pone.0026588. Epub 2011 Oct 26.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Proteomic analysis of urine exosomes by multidimensional protein identification technology (MudPIT).
Proteomics. 2012 Jan;12(2):329-38. doi: 10.1002/pmic.201100477. Epub 2011 Dec 16.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin (Lactollin)P01888Bovine milk exosome proteome.
J Proteomics. 2012 Feb 16;75(5):1486-92. doi: 10.1016/j.jprot.2011.11.017. Epub 2011 Nov 23.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Proteomic analysis of microvesicles derived from human mesenchymal stem cells.
J Proteome Res. 2012 Feb 3;11(2):839-49. doi: 10.1021/pr200682z. Epub 2011 Dec 28.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769The protein interaction network of extracellular vesicles derived from human colorectal cancer cells.
J Proteome Res. 2012 Feb 3;11(2):1144-51. doi: 10.1021/pr200842h. Epub 2012 Jan 9.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes.
Methods. 2012 Feb;56(2):293-304. doi: 10.1016/j.ymeth.2012.01.002. Epub 2012 Jan 21.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulinF5H6I0Quantitative proteome profiling of normal human circulating microparticles.
J Proteome Res. 2012 Apr 6;11(4):2154-63. doi: 10.1021/pr200901p. Epub 2012 Mar 1.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Proteomic analysis of microvesicles released by the human prostate cancer cell line PC-3.
Mol Cell Proteomics. 2012 Jul;11(7):M111.012914. doi: 10.1074/mcp.M111.012914. Epub 2012 Mar 28.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Proteomic analysis of microvesicles from plasma of healthy donors reveals high individual variability.
J Proteomics. 2012 Jun 27;75(12):3574-84. doi: 10.1016/j.jprot.2012.03.054. Epub 2012 Apr 10.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Proteomic analysis of microvesicles from plasma of healthy donors reveals high individual variability.
J Proteomics. 2012 Jun 27;75(12):3574-84. doi: 10.1016/j.jprot.2012.03.054. Epub 2012 Apr 10.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Proteomic analysis of microvesicles from plasma of healthy donors reveals high individual variability.
J Proteomics. 2012 Jun 27;75(12):3574-84. doi: 10.1016/j.jprot.2012.03.054. Epub 2012 Apr 10.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Proteomic analysis of microvesicles from plasma of healthy donors reveals high individual variability.
J Proteomics. 2012 Jun 27;75(12):3574-84. doi: 10.1016/j.jprot.2012.03.054. Epub 2012 Apr 10.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Restoration of full-length APC protein in SW480 colon cancer cells induces exosome-mediated secretion of DKK-4.
Electrophoresis. 2012 Jul;33(12):1873-80. doi: 10.1002/elps.201100687.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Quantitative proteomic analysis of exosomes from HIV-1-infected lymphocytic cells.
Proteomics. 2012 Jul;12(13):2203-11. doi: 10.1002/pmic.201100376.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Quantitative proteomic analysis of exosomes from HIV-1-infected lymphocytic cells.
Proteomics. 2012 Jul;12(13):2203-11. doi: 10.1002/pmic.201100376.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Biochemical and physical characterisation of urinary nanovesicles following CHAPS treatment.
PLoS One. 2012;7(7):e37279. doi: 10.1371/journal.pone.0037279. Epub 2012 Jul 12.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Biochemical and physical characterisation of urinary nanovesicles following CHAPS treatment.
PLoS One. 2012;7(7):e37279. doi: 10.1371/journal.pone.0037279. Epub 2012 Jul 12.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769In-depth analysis of the secretome identifies three major independent secretory pathways in differentiating human myoblasts.
J Proteomics. 2012 Dec 21;77:344-56. doi: 10.1016/j.jprot.2012.09.008. Epub 2012 Sep 20.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769In-depth analysis of the secretome identifies three major independent secretory pathways in differentiating human myoblasts.
J Proteomics. 2012 Dec 21;77:344-56. doi: 10.1016/j.jprot.2012.09.008. Epub 2012 Sep 20.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Cause or effect of arteriogenesis: compositional alterations of microparticles from CAD patients undergoing external counterpulsation therapy.
PLoS One. 2012;7(10):e46822. doi: 10.1371/journal.pone.0046822. Epub 2012 Oct 8.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Comparative and targeted proteomic analyses of urinary microparticles from bladder cancer and hernia patients.
J Proteome Res. 2012 Dec 7;11(12):5611-29. doi: 10.1021/pr3008732. Epub 2012 Oct 31.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Comparative and targeted proteomic analyses of urinary microparticles from bladder cancer and hernia patients.
J Proteome Res. 2012 Dec 7;11(12):5611-29. doi: 10.1021/pr3008732. Epub 2012 Oct 31.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Improved flow cytometric assessment reveals distinct microvesicle (cell-derived microparticle) signatures in joint diseases.
PLoS One. 2012;7(11):e49726. doi: 10.1371/journal.pone.0049726. Epub 2012 Nov 20.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Improved flow cytometric assessment reveals distinct microvesicle (cell-derived microparticle) signatures in joint diseases.
PLoS One. 2012;7(11):e49726. doi: 10.1371/journal.pone.0049726. Epub 2012 Nov 20.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Improved flow cytometric assessment reveals distinct microvesicle (cell-derived microparticle) signatures in joint diseases.
PLoS One. 2012;7(11):e49726. doi: 10.1371/journal.pone.0049726. Epub 2012 Nov 20.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Two distinct populations of exosomes are released from LIM1863 colon carcinoma cell-derived organoids.
Mol Cell Proteomics. 2013 Mar;12(3):587-98. doi: 10.1074/mcp.M112.021303. Epub 2012 Dec 10.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Two distinct populations of exosomes are released from LIM1863 colon carcinoma cell-derived organoids.
Mol Cell Proteomics. 2013 Mar;12(3):587-98. doi: 10.1074/mcp.M112.021303. Epub 2012 Dec 10.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Proteomic analysis of podocyte exosome-enriched fraction from normal human urine.
J Proteomics. 2013 Apr 26;82:193-229. doi: 10.1016/j.jprot.2013.01.012. Epub 2013 Jan 30.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769A comprehensive characterization of membrane vesicles released by autophagic human endothelial cells.
Proteomics. 2013 Apr;13(7):1108-20. doi: 10.1002/pmic.201200531.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin (Lactollin)P01888Bovine milk proteome: quantitative changes in normal milk exosomes, milk fat globule membranes and whey proteomes resulting from Staphylococcus aureus mastitis.
J Proteomics. 2013 Apr 26;82:141-54. doi: 10.1016/j.jprot.2013.02.013. Epub 2013 Feb 28.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.
Proteomics. 2013 May;13(10-11):1667-71. doi: 10.1002/pmic.201200561. Epub 2013 Apr 23.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.
Proteomics. 2013 May;13(10-11):1667-71. doi: 10.1002/pmic.201200561. Epub 2013 Apr 23.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Proteome profiling of exosomes derived from human primary and metastatic colorectal cancer cells reveal differential expression of key metastatic factors and signal transduction components.
Proteomics. 2013 May;13(10-11):1672-86. doi: 10.1002/pmic.201200562.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Proteome profiling of exosomes derived from human primary and metastatic colorectal cancer cells reveal differential expression of key metastatic factors and signal transduction components.
Proteomics. 2013 May;13(10-11):1672-86. doi: 10.1002/pmic.201200562.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Identification and characterization of proteins isolated from microvesicles derived from human lung cancer pleural effusions.
Proteomics. 2013 Jul;13(14):2125-34. doi: 10.1002/pmic.201200323.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Proteomic characterization of human platelet-derived microparticles.
Anal Chim Acta. 2013 May 7;776:57-63. doi: 10.1016/j.aca.2013.03.023. Epub 2013 Mar 19.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Malaria-infected erythrocyte-derived microvesicles mediate cellular communication within the parasite population and with the host immune system.
Cell Host Microbe. 2013 May 15;13(5):521-34. doi: 10.1016/j.chom.2013.04.009.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Characterization of human thymic exosomes.
PLoS One. 2013 Jul 2;8(7):e67554. doi: 10.1371/journal.pone.0067554. Print 2013.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Characterization of multiple myeloma vesicles by label-free relative quantitation.
Proteomics. 2013 Oct;13(20):3013-29. doi: 10.1002/pmic.201300142.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Characterization of multiple myeloma vesicles by label-free relative quantitation.
Proteomics. 2013 Oct;13(20):3013-29. doi: 10.1002/pmic.201300142.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Quantitative proteomics of extracellular vesicles derived from human primary and metastatic colorectal cancer cells.
J Extracell Vesicles. 2012 Sep 11;1. doi: 10.3402/jev.v1i0.18704. eCollection 2012.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Quantitative proteomics of extracellular vesicles derived from human primary and metastatic colorectal cancer cells.
J Extracell Vesicles. 2012 Sep 11;1. doi: 10.3402/jev.v1i0.18704. eCollection 2012.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Cellular stress conditions are reflected in the protein and RNA content of endothelial cell-derived exosomes.
J Extracell Vesicles. 2012 Apr 16;1. doi: 10.3402/jev.v1i0.18396. eCollection 2012.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Diabetic nephropathy induces changes in the proteome of human urinary exosomes as revealed by label-free comparative analysis.
J Proteomics. 2014 Jan 16;96:92-102. doi: 10.1016/j.jprot.2013.10.037. Epub 2013 Nov 7.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]Q9UD48Exosomal ITGA3 interferes with non-cancerous prostate cell functions and is increased in urine exosomes of metastatic prostate cancer patients.
J Extracell Vesicles. 2013 Dec 23;2. doi: 10.3402/jev.v2i0.22097. eCollection 2013.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Exosomal ITGA3 interferes with non-cancerous prostate cell functions and is increased in urine exosomes of metastatic prostate cancer patients.
J Extracell Vesicles. 2013 Dec 23;2. doi: 10.3402/jev.v2i0.22097. eCollection 2013.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]Q9UD48Exosomal ITGA3 interferes with non-cancerous prostate cell functions and is increased in urine exosomes of metastatic prostate cancer patients.
J Extracell Vesicles. 2013 Dec 23;2. doi: 10.3402/jev.v2i0.22097. eCollection 2013.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Exosomal ITGA3 interferes with non-cancerous prostate cell functions and is increased in urine exosomes of metastatic prostate cancer patients.
J Extracell Vesicles. 2013 Dec 23;2. doi: 10.3402/jev.v2i0.22097. eCollection 2013.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Quantitative proteomics of fractionated membrane and lumen exosome proteins from isogenic metastatic and nonmetastatic bladder cancer cells reveal differential expression of EMT factors.
Proteomics. 2014 Mar;14(6):699-712. doi: 10.1002/pmic.201300452. Epub 2014 Feb 16.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Quantitative proteomics of fractionated membrane and lumen exosome proteins from isogenic metastatic and nonmetastatic bladder cancer cells reveal differential expression of EMT factors.
Proteomics. 2014 Mar;14(6):699-712. doi: 10.1002/pmic.201300452. Epub 2014 Feb 16.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Quantitative proteomics of fractionated membrane and lumen exosome proteins from isogenic metastatic and nonmetastatic bladder cancer cells reveal differential expression of EMT factors.
Proteomics. 2014 Mar;14(6):699-712. doi: 10.1002/pmic.201300452. Epub 2014 Feb 16.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769In-depth proteomic analyses of ovarian cancer cell line exosomes reveals differential enrichment of functional categories compared to the NCI 60 proteome.
Biochem Biophys Res Commun. 2014 Mar 21;445(4):694-701. doi: 10.1016/j.bbrc.2013.12.070. Epub 2014 Jan 14.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Quantitative proteomics of extracellular vesicles released from human monocyte-derived macrophages upon beta-glucan stimulation.
J Proteome Res. 2014 May 2;13(5):2468-77. doi: 10.1021/pr4012552. Epub 2014 Apr 16.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Proteomic analysis of hypoxia-induced U373MG glioma secretome reveals novel hypoxia-dependent migration factors.
Proteomics. 2014 Jun;14(12):1494-502. doi: 10.1002/pmic.201300554. Epub 2014 May 16.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Proteomic analysis of hypoxia-induced U373MG glioma secretome reveals novel hypoxia-dependent migration factors.
Proteomics. 2014 Jun;14(12):1494-502. doi: 10.1002/pmic.201300554. Epub 2014 May 16.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset.
J Proteomics. 2014 Jun 25;106:191-204. doi: 10.1016/j.jprot.2014.04.028. Epub 2014 Apr 24.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Human T-lymphotropic Virus Type 1-infected Cells Secrete Exosomes That Contain Tax Protein.
J Biol Chem. 2014 Aug 8;289(32):22284-305. doi: 10.1074/jbc.M114.549659. Epub 2014 Jun 17.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Human T-lymphotropic Virus Type 1-infected Cells Secrete Exosomes That Contain Tax Protein.
J Biol Chem. 2014 Aug 8;289(32):22284-305. doi: 10.1074/jbc.M114.549659. Epub 2014 Jun 17.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Pathologic Mechanical Stress and Endotoxin Exposure Increases Lung Endothelial Microparticle Shedding.
Am J Respir Cell Mol Biol. 2014 Jul 16.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Extravillous trophoblast cells-derived exosomes promote vascular smooth muscle cell migration.
Front Pharmacol. 2014 Aug 11;5:175. doi: 10.3389/fphar.2014.00175. eCollection 2014.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Antibody-coupled monolithic silica microtips for highthroughput molecular profiling of circulating exosomes.
Sci Rep. 2014 Aug 29;4:6232. doi: 10.1038/srep06232.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Lipidomic and proteomic characterization of platelet extracellular vesicle subfractions from senescent platelets.
Transfusion. 2014 Oct 21. doi: 10.1111/trf.12874.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Lipidomic and proteomic characterization of platelet extracellular vesicle subfractions from senescent platelets.
Transfusion. 2014 Oct 21. doi: 10.1111/trf.12874.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769A New Workflow for Proteomic Analysis of Urinary Exosomes and Assessment in Cystinuria Patients.
J Proteome Res. 2014 Nov 12.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Perturbations in the urinary exosome in transplant rejection.
Front Med (Lausanne). 2015 Jan 5;1:57. doi: 10.3389/fmed.2014.00057. eCollection 2014.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Vascular Smooth Muscle Cell Calcification is Mediated by Regulated Exosome Secretion.
Circ Res. 2015 Feb 23. pii: CIRCRESAHA.114.305012.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines.
Pigment Cell Melanoma Res. 2015 May 7. doi: 10.1111/pcmr.12380.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines.
Pigment Cell Melanoma Res. 2015 May 7. doi: 10.1111/pcmr.12380.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines.
Pigment Cell Melanoma Res. 2015 May 7. doi: 10.1111/pcmr.12380.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines.
Pigment Cell Melanoma Res. 2015 May 7. doi: 10.1111/pcmr.12380.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines.
Pigment Cell Melanoma Res. 2015 May 7. doi: 10.1111/pcmr.12380.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Exosome enrichment of human serum using multiple cycles of centrifugation.
Electrophoresis. 2015 May 23. doi: 10.1002/elps.201500131.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Exosome enrichment of human serum using multiple cycles of centrifugation.
Electrophoresis. 2015 May 23. doi: 10.1002/elps.201500131.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Microparticles released from Mycobacterium tuberculosis-infected human macrophages contain increased levels of the type I interferon inducible proteins including ISG15.
Proteomics. 2015 Jun 2. doi: 10.1002/pmic.201400610.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Microparticles released from Mycobacterium tuberculosis-infected human macrophages contain increased levels of the type I interferon inducible proteins including ISG15.
Proteomics. 2015 Jun 2. doi: 10.1002/pmic.201400610.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Microparticles released from Mycobacterium tuberculosis-infected human macrophages contain increased levels of the type I interferon inducible proteins including ISG15.
Proteomics. 2015 Jun 2. doi: 10.1002/pmic.201400610.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Microparticles released from Mycobacterium tuberculosis-infected human macrophages contain increased levels of the type I interferon inducible proteins including ISG15.
Proteomics. 2015 Jun 2. doi: 10.1002/pmic.201400610.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Exosomes released by chronic lymphocytic leukemia cells induce the transition of stromal cells into cancer-associated fibroblasts.
Blood. 2015 Jun 22. pii: blood-2014-12-618025.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Exosomes released by chronic lymphocytic leukemia cells induce the transition of stromal cells into cancer-associated fibroblasts.
Blood. 2015 Jun 22. pii: blood-2014-12-618025.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Exosomes released by chronic lymphocytic leukemia cells induce the transition of stromal cells into cancer-associated fibroblasts.
Blood. 2015 Jun 22. pii: blood-2014-12-618025.
ENOG410YTDG289 / 0 / 289
Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3]P61769Exosomes released by chronic lymphocytic leukemia cells induce the transition of stromal cells into cancer-associated fibroblasts.
Blood. 2015 Jun 22. pii: blood-2014-12-618025.
ENOG410YTDG289 / 0 / 289
[1] [2] [3]